Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT04602117
What this trial is testing

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

Who this might be right for
HER2-positive Breast CancerHER2 LowSYD-985+24 more
QuantumLeap Healthcare Collaborative
Testing effectiveness (Phase 2)Study completedNCT00219752
What this trial is testing

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

Who this might be right for
Chronic Myeloid Leukemia
Poitiers University Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05528458
What this trial is testing

Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma
Samsung Medical Center 59
Testing effectiveness (Phase 2)Study completedNCT01770743
What this trial is testing

Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels

Who this might be right for
Anthrax
Emergent BioSolutions 168
Testing effectiveness (Phase 2)WithdrawnNCT01252108
What this trial is testing

Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers

Who this might be right for
Helicobacter Pylori Infection
Sequella, Inc.
Testing effectiveness (Phase 2)Study completedNCT02480608
What this trial is testing

Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
University of Leipzig 113
Very early researchNot Yet RecruitingNCT07635433
What this trial is testing

Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic Sinusitis

Who this might be right for
Chronic Rhinosinusitis With Nasal Polyps
The First Affiliated Hospital of Xinxiang Medical College 108
Not applicableStudy completedNCT03309826
What this trial is testing

Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy

Who this might be right for
Hypertensive Disorder of PregnancySleep Apnea, Obstructive
Dr John Kimoff 48
Not applicableStudy completedNCT02234908
What this trial is testing

Rewards for Tuberculosis Contact Screening

Who this might be right for
TuberculosisDrug-resistant Tuberculosis
Boston University 301
Not applicableNo Longer AvailableNCT01196208
What this trial is testing

A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001

Who this might be right for
Disease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin+1 more
Seagen Inc.
Large-scale testing (Phase 3)UnknownNCT04047758
What this trial is testing

Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer

Who this might be right for
Breast Cancer
Shengjing Hospital 420
Not applicableStudy completedNCT00702858
What this trial is testing

Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer

Who this might be right for
Breast CancerJoint Pain
Legacy Health System 30
Not applicableStudy completedNCT07833215
What this trial is testing

Creating a Positive Perception of Birth Experience: The Effect of Birth Theater

Who this might be right for
Childbirth Experience
Uskudar University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515
What this trial is testing

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 170
Testing effectiveness (Phase 2)Looking for participantsNCT06366347
What this trial is testing

ALPINE: Maintenance Letrozole/Abemaciclib

Who this might be right for
Endometrial CancerRecurrent Endometrial CancerTP53
Dana-Farber Cancer Institute 32
Large-scale testing (Phase 3)Study completedNCT04887948
What this trial is testing

Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2

Who this might be right for
Pneumococcal DiseaseCOVID-19SARS-CoV-2 Infection
Pfizer 570
Testing effectiveness (Phase 2)Study completedNCT04665843
What this trial is testing

Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Hoffmann-La Roche 123
Not applicableStudy completedNCT01805843
What this trial is testing

Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Medical University of Graz 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07826052
What this trial is testing

Chemotherapy Exemption in Elderly Women With Node-Positive ER+/HER2- Breast Cancer

Who this might be right for
Breast CancerAdjuvant Therapy
Fudan University 494
Early research (Phase 1)Ended earlyNCT00100152
What this trial is testing

A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)

Who this might be right for
Leukemia, Lymphoblastic, Acute, T-cellMyelogenous LeukemiaChronic Lymphocytic Leukemia+1 more
Merck Sharp & Dohme LLC 50
Next Page